FrancophonIA/ELRC3.0 huggingface dataset:
English: Patients requiring a titrated daily dose> 8 mg buprenorphine/day may not find this regimen adequate.
Slovenian: Ta režim odmerjanja morda ne bo primeren za bolnike, ki potrebujejo prilagojen dnevni odmerek > 8 mg buprenorfina/dan.
English: NAME OF THE MEDICINAL PRODUCT Suboxone 16 mg/4 mg sublingual tablets
Slovenian: IME ZDRAVILA Suboxone 16 mg/4 mg podjezične tablete
English: Both active substances of Suboxone, buprenorphine and naloxone, are extensively metabolized in the liver, and the plasma levels were found to be higher for both buprenorphine and naloxone in patients with moderate and severe hepatic impairment.
Slovenian: Ugotovili so, da je plazemska raven obeh; buprenorfina in naloksona, višja pri bolnikih z zmerno in hudo okvaro jeter.
English: Absorption
Slovenian: Buprenorfin Absorpcija
English: Each 16 mg/4 mg sublingual tablet contains 16 mg buprenorphine (as hydrochloride) and 4 mg naloxone (as hydrochloride dihydrate).
Slovenian: Ena podjezična tableta zdravila Suboxone 16 mg/4 mg vsebuje 16 mg buprenorfina (v obliki klorida) in 4 mg naloksona (v obliki klorid dihidrata).
English: NAME OF THE MEDICINAL PRODUCT Suboxone 8 mg/2 mg sublingual tablets
Slovenian: IME ZDRAVILA Suboxone 8 mg/2 mg podjezične tablete
English: Sudden withdrawal syndrome caused by taking Suboxone too soon after use of illicit opioids, drug withdrawal syndrome in newborn.
Slovenian: Neznana (pogostnosti iz razpoložljivih podatkov ni mogoče oceniti) Nenaden pojav odtegnitvenega sindroma, ki ga povzroči jemanje zdravila Suboxone prekmalu po uporabi nedovoljenih opioidov, sindrom odtegnitve pri novorojenčkih.
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING PACK OF 7 and 28 TABLETS 2 mg STRENGTH
Slovenian: PODATKI NA ZUNANJI OVOJNINI PAKET 7 in 28 TABLET Z JAKOSTJO 2 mg
English: Talk to your doctor before taking Suboxone if you have:
Slovenian: Pred začetkom jemanja zdravila Suboxone se posvetujte z zdravnikom v primeru:
English: PHARMACOLOGICAL PROPERTIES
Slovenian: Farmakokinetični parametri
English: Each sublingual tablet contains 2 mg buprenorphine (as hydrochloride) and 0.5 mg naloxone (as hydrochloride dihydrate).
Slovenian: Ena podjezična tableta vsebuje 2 mg buprenorfina (v obliki klorida) in 0,5 mg naloksona (v obliki klorid dihidrata).
English: Amblyopia Lacrimal disorder
Slovenian: Očesne bolezni ambliopija motnje solznih žlez konjuktivitis mioza
English: Each 8 mg/2 mg tablet contains 8 mg buprenorphine (as hydrochloride) and 2 mg naloxone (as hydrochloride dihydrate).
Slovenian: Ena podjezična tableta zdravila Suboxone 8 mg/2 mg vsebuje 8 mg buprenorfina (v obliki klorida) in 2 mg naloksona (v obliki klorid dihidrata).
English: Co-administration during buprenorphine/naloxone treatment is contraindicated due to the potentially dangerous interaction that may precipitate a sudden onset of prolonged and intense opioid withdrawal symptoms (see section 4.3).
Slovenian: Zaradi potencialno nevarne interakcije, ki lahko sproži pojav dolgotrajnih in intenzivnih simptomov odtegnitve od opioidov (glejte poglavje 4.3), je sočasno jemanje med zdravljenjem z buprenorfinom/naloksonom kontraindicirano.
English: How to store Suboxone
Slovenian: Shranjevanje zdravila Suboxone
English: Common side effects (may effect up to 1 in 10 people):
Slovenian: Pogosti neželeni učinki (pojavijo se lahko pri največ 1 od 10 bolnikov):
English: The recommended starting dose in adults and adolescents over 15 years of age is one to two Suboxone 2 mg/0.5 mg. An additional one to two Suboxone 2 mg/0.5 mg may be administered on day one depending on the individual patient's requirement.
Slovenian: Dodatni ena ali dve tableti zdravila Suboxone 2 mg/0,5 mg se lahko da prvega dne, kar je odvisno od zahtev posameznega bolnika.
English: Each sublingual tablet contains 16 mg buprenorphine (as hydrochloride) and 4 mg naloxone (as hydrochloride dihydrate).
Slovenian: Ena podjezična tableta vsebuje 16 mg buprenorfina (v obliki klorida) in 4 mg naloksona (v obliki klorid dihidrata).
English: The long half life of methadone should be considered when starting buprenorphine/naloxone.
Slovenian: Ob začetku zdravljenja z buprenorfinom/naloksonom je treba upoštevati dolgo razpolovno dobo metadona.
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING PACK OF 7 and 28 TABLETS 8 mg STRENGTH
Slovenian: PODATKI NA ZUNANJI OVOJNINI PAKET 7 in 28 TABLET Z JAKOSTJO 8 mg
English: HU8 7DS
Slovenian: AUC0-48
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING PACK OF 7 and 28 TABLETS 16 mg STRENGTH
Slovenian: PODATKI NA ZUNANJI OVOJNINI PAKET 7 in 28 TABLET Z JAKOSTJO 16 mg
English: 1.1-fold Increase
Slovenian: 1,1-kratno povečanje
English: Each sublingual tablet contains 8 mg buprenorphine (as hydrochloride) and 2 mg naloxone (as hydrochloride dihydrate).
Slovenian: Ena podjezična tableta vsebuje 8 mg buprenorfina (v obliki klorida) in 2 mg naloksona (v obliki klorid dihidrata).
English: Suboxone can also cause withdrawal symptoms if you stop taking it abruptly.
Slovenian: Če zdravilo Suboxone nehate jemati nenadoma, se lahko pojavijo odtegnitveni simptomi.
English: AUClast
Slovenian: Nalokson
English: MARKETING AUTHORISATION NUMBER(S) EU/1/06/359/005 16 mg sublingual tablets 7
Slovenian: ŠTEVILKA(E) DOVOLJENJA (DOVOLJENJ) ZA PROMET EU/1/06/359/005 16 mg podjezične tablete 7 EU/1/06/359/006 16 mg podjezične tablete 28
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each sublingual tablet contains 8 mg buprenorphine as buprenorphine hydrochloride and 2 mg naloxone as naloxone hydrochloride dihydrate.
Slovenian: NAVEDBA ENE ALI VEČ ZDRAVILNIH UČINKOVIN Ena podjezična tableta vsebuje 8 mg buprenorfina v obliki buprenorfinijevega klorida in 2 mg naloksona v obliki naloksonijevega klorid dihidrata.
English: NAME OF THE MEDICINAL PRODUCT Suboxone 16 mg/4 mg sublingual tablets buprenorphine/naloxone
Slovenian: Navodilo za uporabo Suboxone 16 mg/4 mg podjezične tablete buprenorfin/nalokson
English: NAME OF THE MEDICINAL PRODUCT Suboxone 8 mg/2 mg sublingual tablets buprenorphine/naloxone
Slovenian: Navodilo za uporabo Suboxone 8 mg/2 mg podjezične tablete buprenorfin/nalokson
English: Abdominal Pain Diarrhoea Dyspepsia Flatulence Vomiting
Slovenian: Bolezni prebavil zaprtost navzea bolečine v trebuhu diareja razjede v ustih obarvanje jezika dispepsija napihnjenost bruhanje
English: Diarrhoea Dyspepsia Flatulence Vomiting
Slovenian: Žilne bolezni hipertenzija vazodilatacija hipotenzija ortostatska hipotenzija
English: NAME OF THE MEDICINAL PRODUCT Suboxone 2 mg/0.5 mg sublingual tablets buprenorphine / naloxone
Slovenian: Navodilo za uporabo Suboxone 2 mg/0,5 mg podjezične tablete buprenorfin/nalokson
English: Clear signs of withdrawal should be evident before taking your first dose of Suboxone.
Slovenian: Preden vzamete prvi odmerek zdravila Suboxone, morajo biti jasno vidni odtegnitveni simptomi.
English: NAME OF THE MEDICINAL PRODUCT Suboxone 16 mg/4 mg sublingual tablets buprenorphine / naloxone
Slovenian: Suboxone 16 mg/4 mg podjezične tablete buprenorfin/nalokson
English: Hallucination
Slovenian: Odmerjanje
English: 3 - Starting from the edge where the seal is lifted, pull back the foil on the back to remove the tablet
Slovenian: Začnite na vogalu, kjer folija ni pritrjena na omot.
English: Alcohol may increase drowsiness and may increase the risk of respiratory failure if taken with Suboxone.
Slovenian: Zdravilo Suboxone skupaj s hrano, pijačo in alkoholom Alkohol lahko ob sočasnem uživanju z zdravilom Suboxone poveča zaspanost in poveča tveganje dihalne odpovedi.
English: Bronchospasm Respiratory mediastinal disorders
Slovenian: Bolezni dihal, prsnega koša in mediastinalnega kašelj astma dispneja zehanje bronhospazem respiratorna depresija prostora
English: MA (EU) number (Invented) name Strength Pharmaceutical form Route of administration
Slovenian: Jakost Farmacevtska oblika Pot uporabe Stična ovojnina
English: Packaging Content (concentration)
Slovenian: Pot uporabe Ovojnina Vsebina (koncentracija)
English: Cutaneous use tube (alu) 2 g
Slovenian: 78 mg/g gel dermalna uporaba tuba (alu) 2 g
English: Name
Slovenian: Lastniško ime
English: If symptoms last longer than one week a doctor or a qualified healthcare practitioner should be consulted.
Slovenian: Če simptomi trajajo dlje kot en teden, se je treba posvetovati z zdravnikom ali usposobljenim zdravstvenim delavcem.
English: Horsetail herb medicines should be used only in adults and adolescents over the age of 12 years.
Slovenian: Zdravila, ki vsebujejo zel njivske preslice, se smejo uporabljati samo pri odraslih in mladostnikih, starejših od 12 let.
English: Although the results from this study indicated that the horsetail herb preparation did have a mild diuretic effect, only a few individuals were included in the study and the information on the preparation used was limited.
Slovenian: Čeprav so rezultati te študije pokazali, da ima pripravek z zeljo njivske preslice blag diuretični učinek, je bilo v študijo vključenih le nekaj oseb in informacije o uporabljenem pripravku so bile pomanjkljive.
English: This summary is not intended to provide practical advice on how to use medicines containing horsetail herb.
Slovenian: Povzetek ni namenjen zagotavljanju praktičnih nasvetov o uporabi zdravil, ki vsebujejo zel njivske preslice.
English: 30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom production of urine in order to achieve flushing of the urinary tract.
Slovenian: 30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom
English: These include allergic reactions and, when used for minor urinary conditions, mild stomach and gut complaints.
Slovenian: Ti vključujejo alergijske reakcije in, kadar se uporabljajo za blažje težave s sečili, blage želodčne in prebavne težave.
English: Horsetail herb preparations can also be used for treating superficial wounds.
Slovenian: Pripravki z zeljo njivske preslice se lahko uporabljajo tudi za zdravljenje površinskih ran.
English: Further information on the risks associated with horsetail herb medicines, including the appropriate precautions for their safe use, can be found in the monograph under the tab ‘All documents' on the Agency's website: ema.europa.eu/Find medicine/Herbal medicines for human use.
Slovenian: Dodatne informacije o tveganjih, povezanih s temi zdravili, ki vsebujejo zel njivske preslice, vključno z ustreznimi previdnostnimi ukrepi za njihovo varno uporabo, so na voljo v monografiji na spletni strani agencije pod zavihkom „Vsi dokumenti“: ema.europa.eu/Find medicine/Herbal medicines for human use.
English: In its assessment, the HMPC considered a clinical study in healthy male volunteers comparing a horsetail herb preparation with a dummy treatment and a medicine that increases the volume of urine produced (a diuretic).
Slovenian: V svoji oceni je odbor HMPC upošteval klinično študijo na zdravih moških prostovoljcih, v kateri so primerjali pripravek z zeljo njivske preslice z zdravilom brez zdravilne učinkovine in zdravilom, ki poveča količino nastalega urina (diuretikom).
English: The HMPC also noted the lack of clinical studies with horsetail herb for treating superficial wounds.
Slovenian: Odbor HMPC je prav tako ugotovil pomanjkanje kliničnih študij z zeljo njivske preslice za zdravljenje površinskih ran.
English: How are horsetail herb medicines approved in the EU?
Slovenian: Kako so zdravila, ki vsebujejo zel njivske preslice, odobrena v EU?
English: This is a summary of the scientific conclusions reached by the Committee on Herbal Medicinal Products (HMPC) on the medicinal uses of horsetail herb.
Slovenian: To je povzetek znanstvenih zaključkov Odbora za zdravila rastlinskega izvora (HMPC) v zvezi z medicinsko uporabo zeli njivske preslice.
English: The HMPC conclusions are taken into account by EU Member States when evaluating applications for the licensing of herbal medicines containing horsetail herb.
Slovenian: Ugotovitve odbora HMPC države članice EU upoštevajo pri ocenjevanju vlog za izdajo dovoljenja za promet z zdravili rastlinskega izvora, ki vsebujejo zel njivske preslice.
English: Information on the use and licensing of horsetail herb medicines in EU Member States should be obtained from the relevant national authorities.
Slovenian: Za informacije o uporabi in registraciji zdravil, ki vsebujejo zel njivske preslice, v državah članicah EU se obrnite na pristojni nacionalni organ.
English: Any applications for the licensing of medicines containing horsetail herb have to be submitted to the national authorities responsible for medicinal products, which will assess the application for the herbal medicine and take into account the scientific conclusions of the HMPC.
Slovenian: Vlogo za izdajo dovoljenja za promet z zdravili, ki vsebujejo zel njivske preslice, je treba predložiti pristojnemu nacionalnemu organu za zdravila, ki bo to vlogo za izdajo dovoljenja za promet z zdravilom rastlinskega izvora ocenil in upošteval znanstvene zaključke odbora HMPC.
English: The other herbal preparations of horsetail herb are available in solid or liquid forms to be taken by mouth and in liquid forms to be applied to the skin.
Slovenian: Drugi pripravki rastlinskega izvora z zeljo njivske preslice so na voljo v trdni ali tekoči obliki za jemanje skozi usta in v tekoči obliki za nanos na kožo.
English: The HMPC conclusions on the use of horsetail herb medicines for minor urinary complaints and for superficial wounds are based on their ‘traditional use'.
Slovenian: Zaključki odbora HMPC o uporabi zdravil, ki vsebujejo zel njivske preslice, za zdravljenje blažjih težav s sečili in površinskih ran temeljijo na njihovi „tradicionalni uporabi“.
English: Further information on the HMPC assessment of horsetail herb medicines, including details of the Committee's conclusions, can be found under the tab ‘All documents' on the Agency's website: ema.europa.eu/Find medicine/Herbal medicines for human use.
Slovenian: Dodatne informacije o oceni zdravil, ki vsebujejo zel njivske preslice, ki jo je opravil odbor HMPC, vključno z njegovimi znanstvenimi zaključki, so na voljo na spletni strani agencije pod zavihkom „Vsi dokumenti“: ema.europa.eu/Find medicine/Herbal medicines for human use.
English: Horsetail herb preparations may also be found in combination with other herbal substances in some herbal medicines.
Slovenian: Pripravki z zeljo njivske preslice so v nekaterih zdravilih rastlinskega izvora lahko na voljo tudi v kombinaciji z drugimi rastlinskimi snovmi.
English: Extracts are prepared using a technique to extract compounds from plant material by putting the plant material in a solvent (such as ethanol or water) to dissolve compounds and form a liquid extract.
Slovenian: Ekstrakti se pripravljajo z uporabo tehnike, s katero se spojine ekstrahirajo tako, da se rastlinski material najprej namoči v topilo (npr. etanol ali vodo), v katerem se raztopijo spojine in se pridobi tekoči ekstrakt.
English: Horsetail herb medicines must not be used for minor urinary complaints if a reduced fluid intake is recommended for existing conditions (e.g. severe heart or kidney disease).
Slovenian: Zdravila, ki vsebujejo zel njivske preslice, se ne smejo uporabljati za blage težave s sečili, če je zaradi obstoječih bolezni (npr. hude srčne ali ledvične bolezni) priporočen manjši vnos tekočin.
English: What evidence supports the use of horsetail herb medicines?
Slovenian: Kateri dokazi podpirajo uporabo zdravil, ki vsebujejo zel njivske preslice?
English: Detailed instructions on how to take horsetail herb medicines and who can use them can be found in the package leaflet that comes with the medicine.
Slovenian: Podrobna navodila o jemanju zdravil, ki vsebujejo zel njivske preslice, in o tem, kdo sme ta zdravila jemati, so na voljo v navodilu za uporabo, ki je priloženo posameznemu zdravilu.
English: What is horsetail herb?
Slovenian: Kaj je zel njivske preslice?
English: The HMPC concluded that, on the basis of its long-standing use, these horsetail herb preparations can be used in minor problems affecting the urinary tract (structures that carry urine) to increase the
Slovenian: Odbor HMPC je na podlagi dolgotrajne uporabe zaključil, da se lahko ti pripravki, ki vsebujejo zel njivske preslice, uporabljajo za lajšanje blažjih težav s sečili (strukturami za odvajanje seča (urina)),
English: Therefore, the HMPC conclusions on the uses of horsetail herb medicines are based on their long-standing use.
Slovenian: Zaključki odbora HMPC v zvezi z uporabo zdravil, ki vsebujejo zel njivske preslice, zato temeljijo na njihovi dolgotrajni uporabi.
English: What are the risks associated with horsetail herb medicines?
Slovenian: Kakšna tveganja so povezana z zdravili, ki vsebujejo zel njivske preslice?
English: Herbal medicines containing comminuted horsetail herb are usually available as herbal tea to be drunk or as infusion or decoction to be applied to the skin.
Slovenian: Zdravila rastlinskega izvora, ki vsebujejo zdrobljeno zel njivske preslice, so navadno na voljo kot zdravilni čaj, ki se popije, ali kot poparek ali prevretek za nanos na kožo.
English: Other information about horsetail herb medicines
Slovenian: Druge informacije o zdravilih, ki vsebujejo zel njivske preslice
English: For more information about treatment with horsetail herb medicines, read the package leaflet that comes with the medicine or contact your doctor or pharmacist.
Slovenian: Za več informacij o zdravljenju z zdravili, ki vsebujejo zel njivske preslice, preberite navodilo za uporabo, ki je priloženo posameznemu zdravilu, ali se posvetujte z zdravnikom ali farmacevtom.
English: For practical information about using horsetail herb medicines, patients should read the package leaflet that comes with the medicine or contact their doctor or pharmacist.
Slovenian: Za praktične informacije o njihovi uporabi naj bolniki preberejo navodilo za uporabo, ki je priloženo posameznemu zdravilu, ali se posvetujejo z zdravnikom ali farmacevtom.
English: The HMPC conclusions only cover horsetail herb preparations which are obtained by drying and comminuting (reducing into tiny pieces) the aerial parts of the plant, by expressing the juice of the fresh aerial parts and as dry or liquid extracts from the dried aerial parts.
Slovenian: Zel njivske preslice je splošno ime za nadzemne dele rastline Equisetum arvense L. Zaključki odbora HMPC zajemajo samo pripravke z zeljo njivske preslice, ki se pridobivajo s sušenjem in drobljenjem (zmanjševanjem na majhne delce) nadzemnih delov rastline, z iztiskanjem soka iz svežih nadzemnih delov in kot suhi ali tekoči ekstrakti posušenih nadzemnih delov.
English: Side effects have been reported with horsetail herb medicines.
Slovenian: Pri uporabi zdravil, ki vsebujejo zel njivske preslice, so poročali o neželenih učinkih.
English: For dry extracts the solvent is then evaporated.
Slovenian: Topilo se nato odpari, s čimer se pridobi suhi ekstrakt.
English: Horsetail herb
Slovenian: Zel njivske preslice
English: The ratio was approved in the 1990s.
Slovenian: Razmerje je bilo odobreno v 1990-ih.
English: 2.1 Critical Evaluation
Slovenian: 2.1 Kritično vrednotenje
English: The biggest problem is huge regional even local differences across Europe and within countries.
Slovenian: Največja težava so velike regionalne in celo lokalne razlike v Evropi in znotraj držav.
English: • Head and neck
Slovenian: • glava in vrat
English: Most statements were either already covered by the proposed harmonised text, or lacked supportive evidence.
Slovenian: Izjave so bile večinoma že skladne s predlaganim usklajenim besedilom ali pa so jim manjkali podporni dokazi.
English: Thus the 16:1 ratio should be effective in all indications where efficacy of the other formulations has been shown.
Slovenian: Zato bi moralo biti razmerje 16:1 učinkovito v vseh indikacijah, kjer je dokazana učinkovitost drugih formulacij.
English: Prior to harmonisation, at start of procedure, the indications for the various ratios were grouped as follows:
Slovenian: Pred usklajevanjem, na začetku postopka, so bile indikacije različnih razmerij razvrščene v naslednje skupine:
English: Dosing recommendations in this population can therefore not be made.
Slovenian: Priporočila za odmerjanje v tej populaciji niso možna.
English: Consideration should be given to official guidance on the appropriate use of antibacterial agents.”
Slovenian: Upoštevati je treba uradna priporočila o primerni uporabi protibakterijskih zdravil.“
English: Treatment should not be extended beyond 14 days without review.
Slovenian: Brez pregleda zdravljenje ne sme biti daljše od 14 dni.
English: “Symptoms and signs of overdose
Slovenian: „Simptomi in znaki prekomernega odmerjanja
English: Similarly, Sections 6.1, 6.2, 6.3, 6.4 and 6.5 will also be completed nationally.
Slovenian: Tudi poglavja 6.1, 6.2, 6.3, 6.4 in 6.5. dopolnijo države članice.
English: This ratio is not recommended for use in children less than six years of age.
Slovenian: To razmerje ni priporočeno za uporabo pri otrocih, mlajših od šest let.
English: This set of indications differs from that for the lower ratio formulations.
Slovenian: Ta nabor indikacij se razlikuje od formulacij z nižjim razmerjem.
English: This is a particularly important section for antibacterials.
Slovenian: To je posebno pomembno poglavje za protibakterijska zdravila.
English: “The duration of therapy should be determined by the response of the patient.
Slovenian: „Trajanje zdravljenja se določi na osnovi odziva bolnika.
English: These indications are approved in all EU countries and Augmentin is accepted as an effective treatment in several national guidelines.
Slovenian: Te indikacije so odobrene v vseh državah EU in Augmentin je sprejet kot učinkovito zdravljenje v več nacionalnih smernicah.
English: For Section 6.6, there are “No special requirements” for disposal of surplus materials.
Slovenian: V poglavju 6.6 je izjava „Ni posebnih zahtev“ za odstranjevanje odvečnega zdravila.
English: Section 4.5 - Interaction with other medicinal products, and other forms of interaction
Slovenian: Poglavje 4.5 - Medsebojno delovanje z drugimi zdravili in druge oblike interakcij
English: Therefore an alternative presentation of Augmentin should be selected.”
Slovenian: Zato je treba izbrati alternativno obliko zdravila Augmentin.“
English: The choice of presentations used in any one EU MS needs to be tailored to the prevalence of certain types of bacterial resistance, which is very variable between EU countries and will inevitably change over time.
Slovenian: Izbiro oblike, ki se uporabi v vsaki državi članici EU, je treba prikrojiti pogostnosti določene vrste bakterijske odpornosti, ki se zelo razlikuje med državami EU in se bo gotovo spreminjala s časom.
English: Hence, the daily dose of clavulanic acid will depend upon the frequency of administration and not the formulation.
Slovenian: Zato je dnevni odmerek klavulanske kisline odvisen od pogostnosti uporabe in ne od formulacije.
English: Sections 1, 2 and 3 are to be completed nationally.
Slovenian: Poglavja 1, 2 in 3 dopolnijo države članice.
English: Data on a few hundreds of patients and a summary of the clinical data in support of the treatment of osteomyelitis were provided.
Slovenian: Predloženi so bili podatki o nekaj sto bolnikih in povzetek kliničnih podatkov v podporo zdravljenju osteomielitisa.
English: “Not all the possible presentations of Augmentin suitable for use in all EU countries.
Slovenian: „Vse oblike zdravila Augmentin niso primerne za uporabo v vseh državah EU.
English: These features make it an appropriate antibiotic for intra-abdominal infections.
Slovenian: Zaradi teh lastnosti je primeren antibiotik za intraabdominalne okužbe.
English: PACKAGE LEAFLET AND USER TESTING
Slovenian: NAVODILO ZA UPORABO IN PRESKUŠANJE PRI UPORABNIKIH
English: This standard daily dose should not be exceeded, and is in fact a maximum daily dose contributing to the safe use of Augmentin.
Slovenian: Ta standardni dnevni odmerek se ne sme preseči, saj je dejansko največji dnevni odmerek, ki prispeva k varni rabi zdravila Augmentin.